Skip to content
10-K/A

Annual Report

Citius Pharmaceuticals, Inc. CTXR

0001213900-26-008861

← back to feed
Filed
Jan 28, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Dec 17, 2025 20.76M sh